Connect with us

Globe Trotting

Philips and CAMTech develop an innovative resuscitation device to reduce neonatal mortality

On the occasion of the 73rd Session of the United Nations General Assembly (UNGA 73), Royal Philips announced successful development of the augmented infant resuscitator (AIR) – an add-on device for conventional neonatal bag-valve-mask (BVM) resuscitators that helps caregivers to effectively resuscitate asphyxiated newborn babies. Developed in collaboration with the Consortium for Affordable Medical Technologies (CAMTech) at Massachusetts General Hospital Global Health, Philips AIR aims to reduce neonatal mortality, especially in parts of the world that are underserved in terms of healthcare. It is expected to be available in limited volume in selected markets prior to scaling up availability in low- and middle-income countries.

The AIR device is an innovative add-on that is compatible with virtually all existing manual BVM resuscitators. It has the potential to significantly improve the initial training and ongoing practice of BVM resuscitation skills. Philips recently obtained a license for the relevant Intellectual Property owned by Partners Healthcare and Mbarara University of Science and Technology, to commercialize and scale the AIR device.

CAMTech will continue to gather new impact, usability, and cost-effectiveness data through a multi-country trial in India, Uganda, and Ghana, for which Philips will provide CAMTech with more than 200 engineering samples.

Copyright © 2024 Medical Buyer

error: Content is protected !!